A study presented at ACR Convergence 2025 suggests that GLP 1 receptor agonists reduce flares and systemic inflammation in Rheumatoid Arthritis (RA) patients.
New Study Finds Diabetes, Weight Loss Drugs May Lower Rheumatoid Arthritis Flares
NDTV Latest10/29146
Raw Story
Detroit Free Press
Cover Media